SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-14-001080
Filing Date
2014-04-29
Accepted
2014-04-29 10:08:12
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q medizone10q033114.htm 10-Q 304476
2 EX-31.1 ex31-1.htm EX-31.1 10242
3 EX-31.2 ex31-2.htm EX-31.2 10077
4 EX-32.1 ex32-1.htm EX-32.1 4146
5 EX-32.2 ex32-2.htm EX-32.2 4542
  Complete submission text file 0001185185-14-001080.txt   2154965

Data Files

Seq Description Document Type Size
6 EX-101.INS mzei-20140331.xml EX-101.INS 206051
7 EX-101.SCH mzei-20140331.xsd EX-101.SCH 29409
8 EX-101.CAL mzei-20140331_cal.xml EX-101.CAL 21909
9 EX-101.DEF mzei-20140331_def.xml EX-101.DEF 124153
10 EX-101.LAB mzei-20140331_lab.xml EX-101.LAB 218525
11 EX-101.PRE mzei-20140331_pre.xml EX-101.PRE 125456
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 14791735
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries